Search Results - "Peterse, Hans"

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas by Kreike, Bas, van Kouwenhove, Marieke, Horlings, Hugo, Weigelt, Britta, Peterse, Hans, Bartelink, Harry, van de Vijver, Marc J

“…Breast cancer is a heterogeneous group of tumors, and can be subdivided on the basis of histopathological features, genetic alterations and gene-expression…”
Get full text

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis by Sotiriou, Christos, Wirapati, Pratyaksha, Loi, Sherene, Harris, Adrian, Fox, Steve, Smeds, Johanna, Nordgren, Hans, Farmer, Pierre, Praz, Viviane, Haibe-Kains, Benjamin, Desmedt, Christine, Larsimont, Denis, Cardoso, Fatima, Peterse, Hans, Nuyten, Dimitry, Buyse, Marc, Van de Vijver, Marc J., Bergh, Jonas, Piccart, Martine, Delorenzi, Mauro

“…Background: Histologic grade in breast cancer provides clinically important prognostic information. However, 30%–60% of tumors are classified as histologic…”
Get full text

Gene expression profiling predicts clinical outcome of breast cancer by Friend, Stephen H, van 't Veer, Laura J, Dai, Hongyue, van de Vijver, Marc J, He, Yudong D, Hart, Augustinus A. M, Mao, Mao, Peterse, Hans L, van der Kooy, Karin, Marton, Matthew J, Witteveen, Anke T, Schreiber, George J, Kerkhoven, Ron M, Roberts, Chris, Linsley, Peter S, Bernards, René

“…Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for…”
Get full text

Predicting a local recurrence after breast-conserving therapy by gene expression profiling by Nuyten, Dimitry S A, Kreike, Bas, Hart, Augustinus A M, Chi, Jen-Tsan Ashley, Sneddon, Julie B, Wessels, Lodewyk F A, Peterse, Hans J, Bartelink, Harry, Brown, Patrick O, Chang, Howard Y, van de Vijver, Marc J

“…To tailor local treatment in breast cancer patients there is a need for predicting ipsilateral recurrences after breast-conserving therapy. After adequate…”
Get full text

BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study by RIJNSBURGER, Adriana J, OBDEIJN, Inge-Marie, PETERSE, Hans, TOLLENAAR, Rob A. E. M, HOOGERBRUGGE, Nicoline, MEIJER, Sybren, BARTELS, Carina C. M, SEYNAEVE, Caroline, HOONING, Maartje J, KRIEGE, Mieke, SCHMITZ, Paul I. M, OOSTERWIJK, Jan C, KAAS, Reinoutje, DE KONING, Harry J, RUTGERS, Emiel J. T, KLIJN, Jan G. M, TILANUS-LINTHORST, Madeleine M. A, BOETES, Carla, LOO, Claudette E, WASSER, Martin N. J. M, BERGERS, Elisabeth, KOK, Theo, MULLER, Sara H

“…The Dutch MRI Screening Study on early detection of hereditary breast cancer started in 1999. We evaluated the long-term results including separate analyses of…”
Get full text

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer by Berns, Anton, Jonkers, Jos, Meuwissen, Ralph, van der Gulden, Hanneke, Peterse, Hans, van der Valk, Martin

“…Inheritance of one defective BRCA2 allele predisposes humans to breast cancer. To establish a mouse model for BRCA2-associated breast cancer, we generated…”
Get full text

Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up by Kreike, Bas, M.D, Hart, Augustinus A.M., M.Sc, van de Velde, Tony, B.Sc, Borger, Jacques, M.D., Ph.D, Peterse, Hans, M.D, Rutgers, Emiel, M.D., Ph.D, Bartelink, Harry, M.D., Ph.D, van de Vijver, Marc J., M.D., Ph.D

“…Purpose Currently, the local treatment of most patients with early invasive breast cancer consists of breast-conserving therapy (BCT). We have previously…”
Get full text

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer by Rodenhuis, Sjoerd, Bontenbal, Marijke, Beex, Louk V.A.M, Wagstaff, John, Richel, Dick J, Nooij, Marianne A, Voest, Emile E, Hupperets, Pierre, van Tinteren, Harm, Peterse, Hans L, TenVergert, Elisabeth M, de Vries, Elisabeth G.E

“…The efficacy of high-dose chemotherapy plus hematopoietic stem-cell rescue for breast cancer with axillary-lymph-node metastases was tested in a multicenter…”
Get full text

Using Histopathology Breast Cancer Data to Reduce Clinical Target Volume Margins at Radiotherapy by Stroom, Joep, Ph.D, Schlief, Angelique, B.Sc, Alderliesten, Tanja, Ph.D, Peterse, Hans, M.D, Bartelink, Harry, M.D., Ph.D, Gilhuijs, Kenneth, Ph.D

“…Purpose This study aimed to quantify the incidence and extension of microscopic disease around primary breast tumors in patients undergoing breast-conserving…”
Get full text

Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy by KREIKE, Bas, HALFWERK, Hans, KRISTEL, Petra, GLAS, Annuska, PETERSE, Hans, BARTEIINK, Harry, VAN DE VIJVER, Marc J

“…Purpose: Several risk factors for local recurrence of breast cancer after breast-conserving therapy (BCT) have been identified. The identification of…”
Get full text

Hereditary breast cancer growth rates and its impact on screening policy by Tilanus-Linthorst, Madeleine M.A., Kriege, Mieke, Boetes, Carla, Hop, Wim C.J., Obdeijn, Inge-Marie, Oosterwijk, Jan C., Peterse, Hans L., Zonderland, Harmine M., Meijer, Sybren, Eggermont, Alexander M.M., de Koning, Harry J., Klijn, Jan G.M., Brekelmans, Cecile T.M.

“…Imaging is often performed yearly for the surveillance of BRCA1/2 mutation carriers and women at high familial breast cancer risk. Growth of cancers in…”
Get full text

Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela by STROBBE, L. J. A, PETERSE, H. L, VAN TINTEREN, H, WIJNMAALEN, A, RUTGERS, E. J. T

“…Purpose. In the past 15 years breast conserving therapy (BCT) has become an important treatment option for primary breast cancer. Thirty three angiosarcomas…”
Get full text

Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma by TAAL, Babs G, PETERSE, Hans, BOOT, Henk

Get full text

Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy by de Bree, Eelco, Zoetmulder, Frans A.N, Keus, Ronald B, Peterse, Hans L, van Coevorden, Frits

“…The incidence of plantar fibromatosis (PF) is unknown. Sometimes PF tends to recur repetitively after surgical treatment. In our institute we have used…”
Get full text

Pathological investigation of sentinel lymph nodes by van Diest, P J, Peterse, H L, Borgstein, P J, Hoekstra, O, Meijer, C J

“…The sentinel lymph-node procedure enables selective targeting of the first draining lymph node, where the initial metastases will form. A negative sentinel…”
Get full text

Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast by CHEN, Yunn-Yi, HWANG, Eun-Sil Shelley, VINCENT-SALOMON, Anne, TOKUYASU, Taku, SCHNITT, Stuart J, WALDMAN, Frederic M, ROY, Ritu, DEVRIES, Sandy, ANDERSON, Joseph, WA, Chrystal, FITZGIBBONS, Patrick L, JACOBS, Timothy W, MACGROGAN, Gaetan, PETERSE, Hans

“…The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are…”
Get full text

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition by Kriege, Mieke, Brekelmans, Cecile T.M, Boetes, Carla, Besnard, Peter E, Zonderland, Harmine M, Obdeijn, Inge Marie, Manoliu, Radu A, Kok, Theo, Peterse, Hans, Tilanus-Linthorst, Madeleine M.A, Muller, Sara H, Meijer, Sybren, Oosterwijk, Jan C, Beex, Louk V.A.M, Tollenaar, Rob A.E.M, de Koning, Harry J, Rutgers, Emiel J.T, Klijn, Jan G.M

“…In a comparison of mammography with magnetic resonance imaging (MRI) for screening women at high risk for breast cancer, MRI was more sensitive but less…”
Get full text

Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma by Stokkel, M P, Peterse, H L

“…Three cases of angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma are presented. Only two similar cases have been documented…”
Get more information

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor by TREURNIET, H. F, ROOKUS, M. A, PETERSE, H. L, HART, A. A., VAN LEEUWEN, F. E

“…To investigate whether overexpression of the neu protein in breast tumors differentiates risk factor patterns for breast cancer, neu protein overexpression was…”
Get full text

The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? by Lakhani, Sunil R, Audretsch, Werner, Cleton-Jensen, Anne-Marie, Cutuli, Bruno, Ellis, Ian, Eusebi, Vincenzo, Greco, Marco, Houslton, Richard S, Kuhl, Christiane K, Kurtz, John, Palacios, Jose, Peterse, Hans, Rochard, France, Rutgers, E.

“…Lobular carcinoma in situ was first described over 60 years ago. Despite the long history, it continues to pose significant difficulties in screening,…”
Get full text